Literature DB >> 12660543

Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy.

Teresa García-Benayas1, Francisco Blanco, Juan José de la Cruz, Vincent Soriano, Juan González-Lahoz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12660543     DOI： 10.1097/00002030-200304110-00021

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  2 in total

1.  HIV-associated lipodystrophy syndrome: A review of clinical aspects.

Authors:  Jean-Guy Baril; Patrice Junod; Roger Leblanc; Harold Dion; Rachel Therrien; Franãois Laplante; Julian Falutz; Pierre Côté; Marie-Nicole Hébert; Richard Lalonde; Normand Lapointe; Dominic Lévesque; Lyse Pinault; Danielle Rouleau; Cécile Tremblay; Benoãt Trottier; Sylvie Trottier; Chris Tsoukas; Karl Weiss
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

2.  Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.

Authors:  Mariana Gerschenson; Courtney Kim; Baiba Berzins; Babafemi Taiwo; Daniel E Libutti; Julia Choi; Diana Chen; Jill Weinstein; Jessica Shore; Barbara da Silva; Elizabeth Belsey; Grace A McComsey; Robert L Murphy
Journal:  J Antimicrob Chemother       Date:  2009-03-25       Impact factor: 5.758
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.